NCT01357330View on ClinicalTrials.gov

Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Solid Tumors
Interventions
DRUG

SAR245408 (XL147)

Pharmaceutical form:capsule and tablet Route of administration: oral

DRUG

MSC1936369B

Pharmaceutical form:capsule Route of administration: oral

Trial Locations (3)

37203

Investigational Site Number 840003, Nashville

02114

Investigational Site Number 840001, Boston

02115

Investigational Site Number 840002, Boston

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY